🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/10/2000 37,13 37,50 34,88 34,88 -5,10% 7,07% 16.817
27/10/2000 37,50 39,00 36,38 36,75 -2,00% 7,00% 9.567
26/10/2000 37,59 38,63 37,13 37,50 +0,00% 3,99% 13.300
25/10/2000 38,63 38,81 37,50 37,50 -2,91% 3,40% 4.983
24/10/2000 39,00 39,00 37,50 38,63 +0,00% 3,85% 8.867
23/10/2000 39,38 39,75 37,50 38,63 -0,96% 5,71% 8.433
20/10/2000 40,50 40,50 37,50 39,00 -3,70% 7,41% 14.467
19/10/2000 38,91 40,50 38,91 40,50 +8,00% 4,10% 18.850
18/10/2000 39,38 39,75 35,63 37,50 -2,91% 10,48% 12.383
17/10/2000 39,75 40,50 37,50 38,63 -0,96% 7,55% 17.100
16/10/2000 37,31 39,00 36,00 39,00 +8,33% 8,04% 15.567
13/10/2000 33,19 36,00 33,00 36,00 +9,09% 9,04% 21.867
12/10/2000 33,28 34,50 31,88 33,00 -1,12% 7,89% 29.233
11/10/2000 35,25 35,63 31,13 33,38 -4,30% 12,77% 29.233
10/10/2000 36,94 37,13 34,50 34,88 -5,10% 7,11% 20.717
09/10/2000 37,78 38,06 34,88 36,75 -2,97% 8,44% 23.150
06/10/2000 39,84 40,50 37,13 37,88 -4,72% 8,47% 14.933
05/10/2000 42,00 42,66 39,75 39,75 -4,50% 6,92% 20.300
04/10/2000 44,25 45,00 39,75 41,63 -4,31% 11,86% 15.467
03/10/2000 44,63 45,75 43,50 43,50 -0,85% 5,04% 11.400
02/10/2000 47,63 47,63 42,38 43,88 -7,14% 11,02% 11.083
29/09/2000 45,38 48,00 43,50 47,25 +1,61% 9,92% 30.767
28/09/2000 44,44 46,50 44,25 46,50 +5,98% 5,06% 10.017
27/09/2000 45,00 46,50 43,88 43,88 +0,86% 5,83% 11.900
26/09/2000 46,31 46,50 42,75 43,50 -6,45% 8,10% 10.583
25/09/2000 48,00 48,00 46,50 46,50 -1,98% 3,13% 18.300
22/09/2000 46,13 47,44 45,00 47,44 -1,17% 5,28% 12.117
21/09/2000 48,75 48,75 47,25 48,00 -1,54% 3,08% 10.783
20/09/2000 48,75 50,25 47,25 48,75 +0,78% 6,15% 13.617
19/09/2000 47,25 49,50 45,38 48,38 +1,57% 8,73% 13.033